Nuveen LLC Invests $61.79 Million in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Nuveen LLC acquired a new stake in Sabra Healthcare REIT, purchasing approximately $61.79 million worth of shares in the first quarter, representing a 1.49% ownership of the company.
• Wall Street analysts have raised their price targets for Sabra Healthcare REIT, with JMP Securities setting a new target of $22.00 and three analysts rating the stock with a "buy" or higher rating.
• Sabra Healthcare REIT recently declared a quarterly dividend of $0.30 per share, resulting in a 6.5% dividend yield, with its dividend payout ratio at 157.89%.

Nuveen LLC purchased a new stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,536,999 shares of the real estate investment trust's stock, valued at approximately $61,791,000. Nuveen LLC owned approximately 1.49% of Sabra Healthcare REIT as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the company. UMB Bank n.a. grew its holdings in Sabra Healthcare REIT by 379.6% in the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after acquiring an additional 1,621 shares during the last quarter. Assetmark Inc. raised its holdings in shares of Sabra Healthcare REIT by 37.8% during the first quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock valued at $63,000 after acquiring an additional 989 shares in the last quarter. Fifth Third Bancorp lifted its stake in Sabra Healthcare REIT by 110.3% in the first quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock worth $67,000 after acquiring an additional 2,011 shares during the period. GF Fund Management CO. LTD. bought a new stake in Sabra Healthcare REIT in the fourth quarter valued at $74,000. Finally, Harbor Capital Advisors Inc. boosted its stake in shares of Sabra Healthcare REIT by 17.2% during the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock valued at $76,000 after purchasing an additional 642 shares in the last quarter. Institutional investors own 99.40% of the company's stock.

Analyst Upgrades and Downgrades

SBRA has been the subject of a number of research reports. Scotiabank increased their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. JMP Securities boosted their price target on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research note on Wednesday, August 6th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $20.00.

Insider Activity

In related news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the sale, the director owned 64,725 shares in the company, valued at approximately $1,179,289.50. This represents a 14.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.10% of the company's stock.

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA traded up $0.19 during trading hours on Monday, hitting $18.65. 731,240 shares of the company's stock traded hands, compared to its average volume of 2,450,658. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. The firm has a market capitalization of $4.47 billion, a P/E ratio of 24.55, a P/E/G ratio of 1.53 and a beta of 0.86. Sabra Healthcare REIT, Inc. has a 52 week low of $15.60 and a 52 week high of $20.03. The business's fifty day moving average price is $18.33 and its two-hundred day moving average price is $17.62.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%. The business had revenue of $189.15 million during the quarter, compared to analyst estimates of $185.64 million. During the same quarter in the prior year, the business posted $0.36 EPS. Sabra Healthcare REIT's revenue for the quarter was up 7.4% compared to the same quarter last year. Equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Friday, August 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.4%. The ex-dividend date is Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio is currently 157.89%.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.